Professional Documents
Culture Documents
(Download PDF) Engineering of Nanobiomaterials Applications of Nanobiomaterials Volume 2 1St Edition Grumezescu Online Ebook All Chapter PDF
(Download PDF) Engineering of Nanobiomaterials Applications of Nanobiomaterials Volume 2 1St Edition Grumezescu Online Ebook All Chapter PDF
Applications of Nanobiomaterials
Volume 2 1st Edition Grumezescu
Visit to download the full and correct content document:
https://textbookfull.com/product/engineering-of-nanobiomaterials-applications-of-nano
biomaterials-volume-2-1st-edition-grumezescu/
More products digital (pdf, epub, mobi) instant
download maybe you interests ...
https://textbookfull.com/product/nanobiomaterials-in-hard-tissue-
engineering-applications-of-nanobiomaterials-volume-4-1st-
edition-grumezescu/
https://textbookfull.com/product/nanobiomaterials-in-soft-tissue-
engineering-applications-of-nanobiomaterials-volume-5-1st-
edition-grumezescu/
https://textbookfull.com/product/surface-chemistry-of-
nanobiomaterials-applications-of-nanobiomaterials-volume-3-1st-
edition-grumezescu/
https://textbookfull.com/product/nanobiomaterials-in-cancer-
therapy-applications-of-nanobiomaterials-volume-7-1st-edition-
grumezescu/
Nanobiomaterials in Antimicrobial Therapy. Applications
of Nanobiomaterials Volume 6 1st Edition Grumezescu
https://textbookfull.com/product/nanobiomaterials-in-
antimicrobial-therapy-applications-of-nanobiomaterials-
volume-6-1st-edition-grumezescu/
https://textbookfull.com/product/fabrication-and-self-assembly-
of-nanobiomaterials-applications-of-nanobiomaterials-
volume-1-1st-edition-grumezescu/
https://textbookfull.com/product/applications-of-biophotonics-
and-nanobiomaterials-in-biomedical-engineering-1st-edition-
mohammad-e-khosroshahi/
https://textbookfull.com/product/nanobiomaterials-nanostructured-
materials-for-biomedical-applications-narayan/
https://textbookfull.com/product/rock-mechanics-and-rock-
engineering-volume-2-applications-of-rock-mechanics-rock-
engineering-1st-edition-omer-aydan/
Engineering of
Nanobiomaterials
Applications of
Nanobiomaterials
Engineering of
Nanobiomaterials
Applications of
Nanobiomaterials
Edited by
Alexandru Mihai Grumezescu
Department of Science and Engineering of Oxide Materials and
Nanomaterials, Faculty of Applied Chemistry and Materials Science,
University Politehnica of Bucharest, Romania
xv
xvi List of contributors
John G. Hardy
Lancaster University, Department of Chemistry and Materials Science Institute,
Lancaster, England
Vladislav G. Il’ves
Institute of Electrophysics, Ural Branch of the Russian Academy of Sciences,
Yekaterinburg, Russia; Ural Federal University, Yekaterinburg, Russia
Pravin Jagadale
Department of Applied Science and Technology (DISAT) Politecnico di Torino,
Torino, Italy
Hyo-Eon Jin
Physical Biosciences Division, Lawrence Berkeley National Laboratory
Berkeley, CA, USA; Department of Bioengineering, University of California,
Berkeley, CA, USA
Anjali Joshi
Centre for Nanoscience and Nanotechnology, U.I.E.A.S.T, Panjab University,
Chandigarh, India
Amália S. Jurado
CNC Center for Neuroscience and Cell Biology, University of Coimbra,
Coimbra, Portugal; Department of Life Sciences, University of Coimbra,
Coimbra, Portugal
Okan Karatay
Department of Electrical and Electronics Engineering, Baskent University,
Ankara, Turkey
Louis Kavitha
Department of Physics, School of Basic and Applied Sciences, Central
University of Tamil Nadu, Thiruvarur, Tamilnadu, India
Seung-Wuk Lee
Physical Biosciences Division, Lawrence Berkeley National Laboratory
Berkeley, CA, USA; Department of Bioengineering, University of California,
Berkeley, CA, USA
M. Luı́sa do Vale
UCIBIO/REQUIMTE, Department of Chemistry and Biochemistry, Faculty of
Science, University of Porto, Porto, Portugal
Zdenka Maderova
Department of Nanobiotechnology, Institute of Nanobiology and Structural
Biology of GCRC, Ceske Budejovice, Czech Republic
Eduardo F. Marques
Centro de Investigação em Quı́mica, Department of Chemistry and
Biochemistry, Faculty of Science, University of Porto, Porto, Portugal
List of contributors xvii
David K. Mills
School of Biological Sciences and the Center for Biomedical Engineering and
Rehabilitation Science (CBERS), Louisiana Tech University, Ruston, LA, USA
Nishi Mody
Department of Pharmaceutical Sciences, Dr. H. S. Gour Vishwavidyalaya,
Sagar, Madhya Pradesh, India
Masoud Mozafari
Bioengineering Research Group, Nanotechnology and Advanced Materials
Department, Materials and Energy Research Center (MERC), Tehran, Iran
Sina Moztarzadeh
Biomaterials Group, Amirkabir University of Technology, Tehran, Iran
Goldie oza
Department of Electrical Engineering (SEES), CINVESTAV-IPN, Mexico City, DF,
Mexico
Maria C. Pedroso de Lima
CNC Center for Neuroscience and Cell Biology, University of Coimbra,
Coimbra, Portugal
Tamara Perchyonok
Research Development and Innovation, VTPCHEM PTY LTD, Gold Coast,
QLD, Australia
Kristyna Pospiskova
Regional Centre of Advanced Technologies and Materials, Palacky University,
Olomouc, Czech Republic
Fuzhan Rahmanian
Biomaterials Group, Amirkabir University of Technology, Tehran, Iran
Durairajan Rajeswari
Department of Chemistry, Periyar University, Salem, Tamilnadu, India;
Department of Physics, Periyar University, Salem, Tamilnadu, India
Arash Ramedani
Institute for Nanoscience & Nanotechnology (INST), Sharif University of
Technology, Tehran, Iran
Subramanian Ramya
Department of Chemistry, Periyar University, Salem, Tamilnadu, India
Manisekaran Ravichandran
Program on Nanoscience and Nanotechnology, CINVESTAV-IPN, Mexico City,
DF, Mexico
Vanessa Reher
School of Dentistry and Oral Health, Griffith University, Australia
xviii List of contributors
Ivo Safarik
Department of Nanobiotechnology, Institute of Nanobiology and Structural
Biology of GCRC, Ceske Budejovice, Czech Republic; Regional Centre of
Advanced Technologies and Materials, Palacky University, Olomouc, Czech
Republic
Mirka Safarikova
Department of Nanobiotechnology, Institute of Nanobiology and Structural
Biology of GCRC, Ceske Budejovice, Czech Republic
Rajeev Sharma
Department of Pharmaceutical Sciences, Dr. H. S. Gour Vishwavidyalaya,
Sagar, Madhya Pradesh, India
Sandra G. Silva
Centro de Investigação em Quı́mica, Department of Chemistry and
Biochemistry, Faculty of Science, University of Porto, Porto, Portugal
Narinder Singh
Dr SS Bhatnagar University Institute of Chemical Engineering & Technology,
Panjab University, Chandigarh, India
Sergey Yu. Sokovnin
Institute of Electrophysics, Ural Branch of the Russian Academy of Sciences,
Yekaterinburg, Russia; Ural Federal University, Yekaterinburg, Russia
Steven Tom
Department of Materials Science and Engineering, University of California,
Berkeley, CA, USA; Physical Biosciences Division, Lawrence Berkeley National
Laboratory Berkeley, CA, USA
Vladimir P. Torchilin
Center for Pharmaceutical Biotechnology and Nanomedicine, Northeastern
University, Boston, MA, USA; Department of Biochemistry, King Abdulaziz
University, Jeddah, Saudi Arabia
Subramaniam Velumani
Department of Electrical Engineering (SEES), CINVESTAV-IPN, Mexico City, DF,
Mexico; Program on Nanoscience and Nanotechnology, CINVESTAV-IPN,
Mexico City, DF, Mexico
Gaurav Verma
Dr SS Bhatnagar University Institute of Chemical Engineering & Technology,
Panjab University, Chandigarh, India; Centre for Nanoscience and
Nanotechnology, U.I.E.A.S.T, Panjab University, Chandigarh, India;
Department of Chemical Engineering, Massachusetts Institute of Technology,
Cambridge, MA, USA
List of contributors xix
The era of nanosized materials is now considered the center of the evolution of
future tools and emerging technologies with wide applications in industry,
research, health, and beyond. Despite recent scientific progress, biological appli-
cations of nanomaterials are far from being depleted and current knowledge is
limited by the poor access to significant data, but also by widespread and usually
unfounded speculation. Although exhaustive, the current literature is difficult to
reach and understand because of the specificity and strict focuses of researchers
investigating different applications of nanomaterials.
In this context, the scientific series entitled “Applications of Nanobiomaterials”
was motivated by the desire of the Editor, Alexandru Mihai Grumezescu, and
others to bring together comprehensive, up-to-date and relevant findings on the
field of biological applications of nanostructure materials, to promote the knowl-
edge and expand our vision regarding future perspectives. Even though the
approached domain is quite specific and research-oriented, this multivolume set is
easily intelligible for a wide audience including: under-graduate and post-graduate
students, engineers, researchers, academic staff, pharmaceutical companies, bio-
medical sector, and industrial biotechnologies. However, some basic knowledge of
the field of materials science (nanobiomaterials, pharmaceutical industry, products
for medicinal treatments, nanoarchitectonics for delivery of biological active mole-
cules and release, bone implants and stomatology) and engineering is a requisite
for understanding technical aspects.
The selected authors of each chapter are outstanding specialists in the field of
nanobiomaterials, who have made impressive contributions in a specific area of
research or applied area within the scope of this book.
Each of the 11 volumes of the series contains 15 chapters, addressing the most
relevant and recent matters on the field of the volume.
The first volume, Fabrication and Self-Assembly of Nanobiomaterials, intro-
duces the reader to the amazing field of nanostructured materials and offers inter-
esting information regarding the fabrication and assembly of these nanosized
structures. In Volume II, entitled Engineering of Nanobiomaterials, readers can
easily find the most commonly investigated methods and approaches for obtaining
tailored nanomaterials for a particular application, especially those with a great
deal of significance in the biomedical field. In the following step, readers will dis-
cover the importance and the ways of modifying the surface of nanostructured
materials to obtain bioactive materials, by reading Volume III, Surface Chemistry
of Nanobiomaterials. Starting with Volume IV Nanobiomaterials in Hard Tissue
Engineering and Volume V Nanobiomaterials in Soft Tissue Engineering the bio-
medical applications of engineered nanomaterials are revealed and discussed,
focusing on one of the most impacted fields, tissue engineering. Volume VI,
Nanobiomaterials in Antimicrobial Therapy, highlights the potential of different
xxi
xxii Preface of the series
Ecaterina Andronescu
Department of Science and Engineering of Oxide Materials and Nanomaterials
Faculty of Applied Chemistry and Materials Science
University Politehnica of Bucharest, Bucharest, Romania
Preface
xxiii
xxiv Preface
magnetic particles have been widely developed, usually showing no adverse effect
on cell proliferation and functionalities while conferring magnetic properties to
various cell types.
In Chapter 6, Aptamers as functional bionanomaterials for sensor applica-
tions, Tom et al., present an up-to-date review focused on the development of
aptamers as recognition elements. The authors also describe their incorporation
into materials and sensor devices, with the ultimate goal of detecting various
chemical and biological targets with high sensitivity and selectivity.
Cardoso et al., in Chapter 7, entitled Gene delivery mediated by gemini surfac-
tants: structure activity relationships, describe the structural characteristics of gem-
ini surfactants that are correlated with their biological impact on cells, in terms of
adverse effects produced and with capacity to deliver and promote the expression of
nucleic acids. Examples from the literature illustrate the ability of these complexes
to circumvent biological barriers associated with the different steps leading to gene
expression, with emphasis on membrane translocation and endosomal escape.
Chapter 8, Nanobiomaterials for bionic eye: vision of the future, discusses the
current role of nanobiomaterials in visual prosthesis progress and touches on the
future possibilities of this technology.
Perchyonok et al., in Chapter 9, Bioactive-functionalized interpenetrating
network hydrogel (BIOF-IPN), reveal the advances in basic material science,
biotechnology, and designer functional materials. It has the specific aim of
exploiting molecular mechanistics, understanding of conventional free radicals
towards finding, and harnessing a broad range of biologically relevant processes
such as bio-adhesion, biocompatibility, biorepair, and topical drug delivery. The
advantage of the novel intelligent designed functional material—BIOF-INP—is
its amalgamation of molecular design, mechanism, bioanalytical advancement,
and molecular biology. Furthermore, it presents the ability to easily refocus the
aim of the problem, making its applications only limited by the imagination.
Singh et al., in Chapter 10, Engineered nanomaterials for biomedicine:
advancements and hazards, describe the ways in which the interaction of nanoma-
terials with biomolecules can be controlled for beneficial biomedical applications.
This chapter highlights different types of engineered nanomaterials currently used
in biomedical applications and provides a critical overview of the recent advance-
ments and their potential hazards and drawbacks.
Han et al., in Chapter 11, Mechanism of nanomachining semiconductor and
ceramic blades for surgical applications, investigate the mechanisms of ductile
machining ceramic/silicon using DEM/MD method.
Chapter 12, Design and implementation of an electrospinning system, aims
to provide a brief introduction to the electrospinning process for obtaining nanofi-
bers by using personalized, up-to-date novel modeling techniques. Moreover,
the feasibility of suppressing the bending instability due to the complicated
oscillations of a polymer jet was investigated with experimental observations and
mathematical models are also developed.
xxvi Preface
Engineering of
stimuli-sensitive
nanopreparations to
overcome physiological
1
barriers and cancer
multidrug resistance
1.1 INTRODUCTION
Cancer is a major health problem worldwide in terms of mortality and morbidity.
The main therapeutic approach in clinics for the treatment of both localized and
metastatic tumors is chemotherapy. Although chemotherapy is the most common
approach, the crucial problem is that anticancer drugs often lack specificity and
selectivity for cancer cells. Since the cancer therapeutics are highly hydrophobic
and cytotoxic, they fail in the treatment because of a lack of effectiveness and
side effects. In addition to the toxicity that is generally observed in rapidly divid-
ing cells in the body (such as hair, spleen, liver), many widely used chemothera-
peutics include solvents (such as castor oil and polysorbate 80) to provide drug
solubility which is a key factor for systemic/intravenous administration. These
solvents are known to be directly involved with adverse effects. Currently,
conventional chemotherapeutics are substantially limited by (i) systemic cytotox-
icity, (ii) insufficient ability to bypass biological barriers, (iii) poor biodistribution
and nonspecific delivery, and (iv) development of drug resistance.
Nanotechnology, although not a new concept, has gained significant momentum
in the past few decades, especially in the area of cancer research. Briefly, the
expected features of an effective nanoparticulate system are selective accumulation
in the target tissue/organ and an ability to penetrate target cells with loaded drug.
Although nanoparticulate drug delivery systems have several advantages over
conventional therapeutics such as increasing drug stability in vivo and blood circu-
lation time, it has been established that only a small fraction of an administered
dose reaches the tumor site for its intended effect. The primary reasons for an
inability to reach the target site selectively are physiological and cellular barriers.
They are the main protective mechanisms which limit access to organs/tissues.
Additionally, the failure of conventional chemotheraphy is often directly associated
with multidrug resistance (MDR), which is most frequently caused by insufficient
drug concentration at the tumor site. When tumors are exposed to nonoptimal
amounts of drug, they often develop resistance. Higher doses of drug are then
needed to elicit a therapeutic response.
Tumor cells have some unique properties and a microenviroment which is
perhaps more heterogeneous than the other cells of the body. Stimuli-sensitive
drug delivery systems can be engineered based on the specific properties of the
tumor microenvironment, including reduced pH, increased local temperature,
altered redox status, and enzyme activities. This chapter focuses on the
development of stimuli-sensitive nanopreparations with the ability to overcome
physiological barriers and cancer MDR.
and eliminate the drug carrier before it reaches its target site (Owens and Peppas,
2006; Serpe, 2006). Once nanoparticles are coated with plasma proteins (opso-
nized), the macrophages of the liver (Kupffer cells) and spleen rapidly take up
these particles.
The physiochemical characteristics of nanoparticles such as shape, size,
charge, and surface chemistry are determinative for opsonization and clearence
(Kiwada, 1997; Dobrovolskaia et al., 2008; Albanese et al., 2012). To be effec-
tive, the nanoparticulate drug delivery systems must be camouflaged so as to be
unrecognized by the MPS and to avoid phagocytosis by macrophages.
The most common approach to avoid MPS effects and obtain prolonged circula-
tion times by minimizing clearence is by coating nanoparticulate systems with
hydrophilic polymers such as poly(ethylene glycol) (Gref et al., 1995; Storm et al.,
1995). This type of polymer forms dense “conformational clouds” which deny
surface interaction of drug delivery systems (i.e., liposomes, nanoparticles, poly-
meric micelles, dendrimers, quantum dots) with macromolecules (Torchilin and
Trubetskoy, 1995), although, it has been noted that repetitive administration of
pegylated nanoparticles may cause immunogenic responses where the production of
antibodies can promote the blood clearance of nanoparticles. This is known as the
accelerated blood clearance (ABC) phenomenon and is demonstrated for clinically
used pegylated liposomes (Ishida et al., 2006; Abu Lila et al., 2013).
APPENDIX I
THE ORIGINAL CONSTITUTION OF THE UNITED STATES
Article. I.